Search

everythinglearnresearchcommunity

for

Search:↓

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Men with early-onset hair loss have a higher risk of metabolic syndrome.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

Early recognition and treatment of Peripheral Arterial Disease is crucial to improve survival and health outcomes.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Hair loss may indicate higher heart risk and metabolic issues.

Medications for PCOS don't seem to raise heart disease risk.

Women with irregular periods have a higher risk of heart disease.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.